Concentration dependent effect of (-)-epicatechin on Na+/K +-ATPase and Ca2+-ATPase inhibition induced by free radicals in hypertensive patients: Comparison with L-ascorbic acid

Phytotherapy Research

Volumn 26, Issue 11, 2012, Pages 1644-1647

  Kumar, Navneet ^a   Kant, Ruchi ^a   Maurya, Pawan Kumar ^b   Rizvi, Syed Ibrahim ^c  

^a JIMMA UNIVERSITY   (Ethiopia)

^b AMITY UNIVERSITY   (India)

^c UNIVERSITY OF ALLAHABAD   (India)

Author keywords

epicatechin; erythrocyte; hypertension; oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASCORBIC ACID; EPICATECHIN; TERT BUTYL HYDROPEROXIDE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; HUMAN; HUMAN CELL; HYPERTENSION; OXIDATIVE STRESS; PHYTOCHEMISTRY;

ASCORBIC ACID; CALCIUM-TRANSPORTING ATPASES; CASE-CONTROL STUDIES; CATECHIN; ENZYME INHIBITORS; HUMANS; HYPERTENSION; MIDDLE AGED; OXIDATIVE STRESS; SODIUM-POTASSIUM-EXCHANGING ATPASE; TERT-BUTYLHYDROPEROXIDE;

EID: 84867888236     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4624     Document Type: Article

References (29)

1. Carafoli E,. 1987. Intracellular calcium homeostasis. Ann Rev Biochem 56: 395-433.
2. Dally S, Chaabane C, Corvazier E, et al,. 2007. Increased expression of plasma membrane Ca(2+)ATPase 4b in platelets from hypertensives: a new sign of abnormal thrombopoiesis?. Platelets 18 (7): 543-549.
3. + changes in other cells involved in blood pressure regulation. J Hum Hypertens 17 (5): 313-318.
4. +-ATPase in genetic hypertension. J Pharmacol Exp Ther 288 (3): 1074-1083.
5. Fiske C, Subbarow Y,. 1925. The colorimetric determination of phosphorus. J Biol Chem 66: 375-400.
6. Grossman E,. 2008. Does increased oxidative stress cause hypertension? Diabetes Care 31: S185-9.
7. Haynes DH,. 1993. Effects of cyclic nucleotides and protein kinases on platelet calcium homeostasis and mobilization. Platelets 5: 231-242.
8. Heemskerk JWM, Sage SO,. 1994. Calcium signaling in platelets and other cells. Platelets 5: 295-316.
9. Jaitovich A, Bertorello AM,. 2010. Salt, Na(+),K(+)-ATPase and hypertension. Life Sci 86: 73-78.
10. Krouf D, Bouchenak M, Mohammedi B, Cherrad A, Belleville JL, Prost JL,. 2003. Change in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects. Med Sci Monit 9 (8): 1109-1115.
11. Kumar N, Kant R, Maurya PK,. 2010. Concentration dependent effect of (-) epicatechin in hypertensive patients. Phytother Res 24 (10): 1433-1436.
12. Lacy FO, Counor DT, Schmid-Schonbein GW,. 1998. Plasma hydrogen peroxide production in hypertensive and normotensive subjects at genetic risk of hypertension. J Hypertens 16: 291-303.
13. Le Sang Quan KH, Levenson J, Del Pino M, Simon A, Devynck MA,. 1993. In vivo shear flow and erythrocyte membrane fluidity in hypertensive patients. Br J Clin Pharmacol 36 (5): 437-443.
14. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ,. 1951. Protein measurement with the Folin-Phenol reagent. J Biol Chem 193: 265-275.
15. Maurya PK, Prakash S,. 2011. Intracellular uptake of (-) epicatechin by human erythrocytes as a function of human age. Phytother Res 25: 944-946.
16. Maurya PK, Rizvi SI,. 2009. Protective role of tea catechins on erythrocytes subjected to oxidative stress during human aging. Nat Prod Res 23 (12): 1072-1079.
17. +-ATPase activity in human endothelial cells. Atherosclerosis 142 (2): 327-333.
18. Morrissey PA, Quinn PB, Sheehy PJA,. 1994. Newer aspects of micronutrients in chronic disease: E vitamin. Proc Nutr Soc 53: 571-82.
19. Pandey KB, Rizvi SI,. 2009. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2 (5): 270-278.
20. Rizvi SI, Luqman S,. 2003. Capsaicin-induced activation of erythrocyte membrane sodium/potassium and calcium adenosine triphosphatases. Cell Mol Biol Lett 8: 919-925.
21. Rizvi SI, Zaid MA,. 2005. Impairment of sodium pump and Na/H exchanger in erythrocytes from NIDDM patients. Effect of tea catechins. Clin Chim Acta 354: 59-67.
22. Rizvi SI, Zaid MA, Anis R, Mishra N,. 2005. Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes. Clin Exp Pharmacol Physiol 32: 70-75.
23. +-ATPase in diabetes mellitus. Biochem Biophys Res Commun 146: 179-186.
24. Sweadner KJ, Goldin SM,. 1980. Active transport of sodium and potassium ions: mechanism, function and regulation. N Engl J Med 302: 777-783.
25. Thurnham DI,. 1994. Newer aspects of micronutrients in chronic disease: h-carotene, are we misreading the signals in risk groups? Some analogies with vitamin C. Proc Nutr Soc 53: 571-82.
26. Tijburg LBM, Mattern T, Folts JD, Weisgerber UM, Katan MB,. 1997. Tea flavonoids and cardiovascular diseases: a review. Crit Rev Food Sci Nutr 37: 771-785.
27. Tsuchiya H, Nagayama M, Tanaka T, Furusawa M, Kashimata M, Takeuchi H,. 2002. Membrane-rigidifying effects of anti-cancer dietary factors. Biofactors 16 (3-4): 45-56.
28. Vokurková M, Dobesová Z, Pechánová O, Kunes J, Zicha J,. 2003. Erythrocyte ion transport and membrane lipid composition in young and adult rats with NO-deficient hypertension. Life Sci 73 (13): 1037-1044.
29. Weber P, Bendich A, Schalch W,. 1996. Vitamin C and human health-a review of recent data relevant to human requirements. In J Vit Nutr Res 66: 19-30.